← board
RLFTF
distress 0/10 · well-funded / low risk$0.19-4%today-96% from 52w high
Revenue
pre-revenue
Liquidity
$13M
Runway
4.3 yrs
Shares 1y
-100%
Price & events
-88.6% over 6M
CatalystRating changeDilutionFinancingdashed = today
-4.0%
1D
-19.3%
1W
-32.4%
1M
-56.9%
3M
-88.6%
6M
-93.2%
1Y
-84.6%
2Y
-99.8%
5Y
-99.9%
All
Overview
- Market Cap
- $2.41M
- Enterprise Value
- $-10.08M
- Volume
- 5.50K
- 52 Week Range
- $0.19 – $4.50
- Total Shares
- 12.54M
- Float Shares
- 37.20M
- % Held by Insiders
- 48.55%
- % Held by Institutions
- 18.51%
- RVOL
- 1.02x
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 12,540,439 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.